Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Cost-utility of angiotensin-converting enzyme inhibitor compared to thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity

    Access Status
    Fulltext not available
    Authors
    Chowdhury, E.
    Ademi, Z.
    Moss, J.
    Wing, L.
    Reid, Christopher
    Date
    2015
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Chowdhury, E. and Ademi, Z. and Moss, J. and Wing, L. and Reid, C. 2015. 4B.04: Cost-utility of angiotensin-converting enzyme inhibitor compared to thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity. Journal of Hypertension. 33 (e-Supplement: ESH Abstract Book) (14B:04): pp. e53:e54.
    Source Title
    J Hypertens
    DOI
    10.1097/01.hjh.0000467488.12815.b6
    School
    Department of Health Policy and Management
    URI
    http://hdl.handle.net/20.500.11937/44824
    Collection
    • Curtin Research Publications
    Abstract

    OBJECTIVE: To examine the cost-effectiveness of angiotensin-converting enzyme inhibitor-based (ACEI) treatment compared to thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as an outcome along with cardiovascular outcomes from the Australian government perspective. DESIGN AND METHOD: We used a cost-utility analysis to estimate the incremental cost-effectiveness ratio (ICER) per quality-adjusted life-year (QALY) gained. Data on cardiovascular events and new-onset of diabetes were used from the Second Australian National Blood Pressure Study, a randomized clinical trial comparing diuretic-based (hydrochlorothiazide) versus ACEI-based (enalapril) treatment in 6083 elderly (age 65yrs or more) hypertensive patients over a median 4.1-year period. For this economic analysis, the total study population was stratified into two groups. Group A was restricted to participants diabetes-free at baseline (n?=?5,642); and Group B was restricted to participants with pre-existing diabetes mellitus (Type I or Type II) at baseline (n?=?441). Data on utility scores for different events were used from available published literatures; whereas, treatment and adverse event management cost were calculated from direct health care costs available from Australian Government reimbursement data. Quality of life and costs were discounted at 5% per annum. One-way and probabilistic sensitivity analyses were performed to assess the uncertainty around utilities and cost data. RESULTS: After a treatment period of five years, for Group A the ICER was AUD 27,698 (Euro 18,004; AUD 1~ &OV0556; 0.65) per QALY gained comparing ACEI-based with diuretic-based treatment (sensitive to the utility value for new-onset diabetes). In Group B, ACEI-based treatment was a dominant strategy (both more effective and cost-saving). On probabilistic sensitivity analysis, the ICERs per QALY gained were always below AUD 50,000 for Group B; whereas for Group A the probability of being below AUD 50,000 was 85%. CONCLUSIONS: Although the dispensed price of diuretic-based treatment of hypertension in the elderly is lower, upon considering the potential enhanced likelihood of the development of diabetes in addition to the costs of treating cardiovascular disease, ACEI-based treatment may be a more cost-effective strategy in this population.

    Related items

    Showing items related by title, author, creator and subject.

    • Cost–Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity
      Chowdhury, E.; Ademi, Z.; Moss, J.; Wing, L.; Reid, Christopher (2015)
      Abstract: The objective of this study was to examine the cost-effectiveness of angiotensin-converting enzyme inhibitor (ACEI)-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly ...
    • Short-and long-term survival in treated elderly hypertensive patients with or without diabetes: Findings from the second Australian national blood pressure study
      Chowdhury, E.; Owen, A.; Ademi, Z.; Krum, H.; Johnston, C.; Wing, L.; Nelson, M.; Reid, Christopher (2014)
      Background: We sought to determine the incidence of newly diagnosed diabetes in treated elderly hypertensive patients and the prognostic impact of diabetes on long-term survival. Methods: The Second Australian National ...
    • Rate of Change in Renal Function and Mortality in Elderly Treated Hypertensive Patients
      Chowdhury, E.; Langham, R.; Ademi, Z.; Owen, A.; Krum, H.; Wing, L.; Nelson, M.; Reid, Christopher (2015)
      Background and objectives Evidence relating the rate of change in renal function, measured as eGFR, after antihypertensive treatment in elderly patients to clinical outcome is sparse. This study characterized the rate of ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.